Sacramento, C. Q., Fintelman-Rodrigues, N., Temerozo, J. R., Da Silva, A. d. P. D., Dias, S. d. S. G., da Silva, C. d. S., . . . Souza, T. M. L. (2021). In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother.
Style de citation ChicagoSacramento, Carolina Q., et al. "In Vitro Antiviral Activity of the Anti-HCV Drugs Daclatasvir and Sofosbuvir against SARS-CoV-2, the Aetiological Agent of COVID-19." J Antimicrob Chemother 2021.
Style de citation MLASacramento, Carolina Q., et al. "In Vitro Antiviral Activity of the Anti-HCV Drugs Daclatasvir and Sofosbuvir against SARS-CoV-2, the Aetiological Agent of COVID-19." J Antimicrob Chemother 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.